PSP
GILD icon

Principal Street Partners’s Gilead Sciences GILD Stock Holding History

Principal Street Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.36M Sell
58,233
-738
-1% -$97.2K 1.08% 27
2026
Q1 		$8.22M Sell
58,971
-5,919
-9% -$829K 1.34% 17
2025
Q4 		$7.96M Sell
64,890
-1,217
-2% -$148K 1.34% 17
2025
Q3 		$7.34M Sell
66,107
-16,743
-20% -$1.9M 1.17% 19
2025
Q2 		$9.19M Buy
82,850
+6,037
+8% +$642K 0.9% 21
2025
Q1 		$8.61M Buy
76,813
+212
+0.3% +$21.9K 1.6% 11
2024
Q4 		$7.08M Buy
76,601
+609
+0.8% +$54.8K 1.39% 17
2024
Q3 		$6.36M Sell
75,992
-21,930
-22% -$1.67M 1.04% 25
2024
Q2 		$6.72M Buy
97,922
+10,003
+11% +$668K 1.2% 35
2024
Q1 		$6.27M Buy
87,919
+26,658
+44% +$2.05M 1.19% 48
2023
Q4 		$4.96M Sell
61,261
-621
-1% -$48.3K 1.2% 35
2023
Q3 		$4.64M Sell
61,882
-931
-1% -$71.6K 0.92% 33
2023
Q2 		$4.84M Sell
62,813
-1,502
-2% -$120K 1.15% 36
2023
Q1 		$5.34M Sell
64,315
-11,616
-15% -$962K 1.35% 28
2022
Q4 		$6.52M Buy
75,931
+70,689
+1,349% +$5.6M 1.64% 5
2022
Q3 		$324K Buy
5,242
+355
+7% +$22.4K 0.09% 155
2022
Q2 		$302K Buy
4,887
+17
+0.3% +$1.05K 0.08% 162
2022
Q1 		$290K Sell
4,870
-1,091
-18% -$69.7K 0.07% 185
2021
Q4 		$432K Buy
5,961
+267
+5% +$18.4K 0.1% 152
2021
Q3 		$398K Buy
5,694
+191
+3% +$13.4K 0.11% 134
2021
Q2 		$379K Sell
5,503
-6,268
-53% -$419K 0.1% 150
2021
Q1 		$761K Buy
11,771
+7,339
+166% +$473K 0.1% 135
2020
Q4 		$258K Sell
4,432
-49,412
-92% -$2.98M 0.08% 156
2020
Q3 		$3.4M Buy
53,844
+9,174
+21% +$636K 1.2% 44
2020
Q2 		$3.44M Sell
44,670
-12,111
-21% -$928K 1.28% 45
2020
Q1 		$4.25M Buy
56,781
+53,348
+1,554% +$3.69M 1.78% 30
2019
Q4 		$223K Buy
+3,433
New +$224K 0.05% 185

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Principal Street Partners's GILD Position: Q2 2026 in Review

Principal Street Partners reduced its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, selling an estimated $97.2K and leaving 58,233 shares worth $7.36M. The position accounts for 1.08% of the portfolio, ranked #27.

Principal Street Partners first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.19M in Q2 2025. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Principal Street Partners held 58,233 shares of Gilead Sciences worth $7.36M as of Q2 2026.
  • Principal Street Partners sold 738 Gilead Sciences shares in Q2 2026, an estimated $97.2K.
  • Gilead Sciences made up 1.08% of Principal Street Partners's portfolio in Q2 2026, its #27 holding.
  • Principal Street Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Principal Street Partners's Gilead Sciences position peaked at $9.19M in Q2 2025.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Principal Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.